Predicting the risk of chemotherapy-induced neutropenia in patients with breast cancer: rationale for prospective risk model development.
Publication
, Conference
Lyman, GH; Crawford, J; Dale, D; Wolff, DA
Published in: BREAST CANCER RESEARCH AND TREATMENT
2002
Duke Scholars
Published In
BREAST CANCER RESEARCH AND TREATMENT
ISSN
0167-6806
Publication Date
2002
Volume
76
Start / End Page
S135 / S135
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Lyman, G. H., Crawford, J., Dale, D., & Wolff, D. A. (2002). Predicting the risk of chemotherapy-induced neutropenia in patients with breast cancer: rationale for prospective risk model development. In BREAST CANCER RESEARCH AND TREATMENT (Vol. 76, pp. S135–S135).
Lyman, G. H., J. Crawford, D. Dale, and D. A. Wolff. “Predicting the risk of chemotherapy-induced neutropenia in patients with breast cancer: rationale for prospective risk model development.” In BREAST CANCER RESEARCH AND TREATMENT, 76:S135–S135, 2002.
Lyman GH, Crawford J, Dale D, Wolff DA. Predicting the risk of chemotherapy-induced neutropenia in patients with breast cancer: rationale for prospective risk model development. In: BREAST CANCER RESEARCH AND TREATMENT. 2002. p. S135–S135.
Lyman, G. H., et al. “Predicting the risk of chemotherapy-induced neutropenia in patients with breast cancer: rationale for prospective risk model development.” BREAST CANCER RESEARCH AND TREATMENT, vol. 76, 2002, pp. S135–S135.
Lyman GH, Crawford J, Dale D, Wolff DA. Predicting the risk of chemotherapy-induced neutropenia in patients with breast cancer: rationale for prospective risk model development. BREAST CANCER RESEARCH AND TREATMENT. 2002. p. S135–S135.
Published In
BREAST CANCER RESEARCH AND TREATMENT
ISSN
0167-6806
Publication Date
2002
Volume
76
Start / End Page
S135 / S135
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences